Content area

|
|

Den endokrine og metaboliske kobling mellem COVID-19, diabetes og fedme

Forfatter(e)

Nina Weis1, Kristina Thorsteinsson1, Christoffer Martinussen2 & Sten Madsbad2

1) Infektionsmedicinsk Afdeling, Hvidovre Hospital, 2) Endokrinologisk Afdeling, Hvidovre Hospital

Ugeskr Læger 2020;182:V05200381

Reference: 
UgeskrLæger 2020;182:V05200381
The endocrine and metabolic link between COVID-19, diabetes and obesity

Nina Weis, Kristina Thorsteinsson, Christoffer Martinussen & Sten Madsbad

Ugeskr Læger 2020;182:V05200381

Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome corona virus 2. High age, hypertension, diabetes, and obesity are risk factors for severe COVID-19 with increased mortality. In this review, we discuss potential mechanisms by which diabetes and obesity modulate the host viral interactions and host-immune response. Glucose levels should be monitored rigorously, and patient-tailored aggressive treatment of hyperglycaemia is recommended, often with the use of insulin. Persons with diabetes and obesity are susceptible to severe outcomes from COVID-19.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Mats Lindberg | 22/01
1 Kommentar
af Thomas Birk Kristiansen | 22/01
2 kommentarer
af Lars Erik Bryld | 22/01
3 kommentarer
af Lasse Wissing Micheelsen | 20/01
3 kommentarer
af Thomas Sigurd Alber | 20/01
2 kommentarer
af Johan Ludvig Reventlow | 18/01
1 Kommentar
af Bjarne Skjødt Hjaltalin | 18/01
1 Kommentar